In vitro anti-Helicobacter pylori activity of ilaprazole used alone and in combination with other components of quadruple therapy伊拉普拉唑单独使用及与四联疗法其他成分联合使用的体外抗幽门螺杆菌活性MICROBIOLOGY SPECTRUMIF3.82025-09-010PRE
High level non-carbapenemase carbapenem resistance by overlaying mutations of mexR, oprD, and ftsI in Pseudomonas aeruginosaMICROBIOLOGY SPECTRUMIF3.82025-01-070OAAI
Non-antibiotic pharmaceutical phenylbutazone binding to MexR reduces the antibiotic susceptibility of Pseudomonas aeruginosaMICROBIOLOGICAL RESEARCHIF6.92024-11-010OAAI
Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsisACTA BIOMATERIALIAIF9.62024-08-010PRE
Polymyxin resistance caused by large-scale genomic inversion due to IS26 intramolecular translocation in Klebsiella pneumoniaeACTA PHARMACEUTICA SINICA BIF14.62023-09-015OAAI
Antibacterial Activity of an FtsZ Inhibitor Celastrol and Its Synergistic Effect with Vancomycin against Enterococci In Vitro and In VivoMICROBIOLOGY SPECTRUMIF3.82023-02-1410OAAI
ML364 exerts the broad-spectrum antivirulence effect by interfering with the bacterial quorum sensing systemFRONTIERS IN MICROBIOLOGYIF4.52022-12-225OAAI
CrrAB regulates PagP-mediated glycerophosphoglycerol palmitoylation in the outer membrane of Klebsiella pneumoniaeJOURNAL OF LIPID RESEARCHIF4.12022-09-016OAAI
Proteomic Changes of Klebsiella pneumoniae in Response to Colistin Treatment and crrB Mutation-Mediated Colistin ResistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52020-05-2135OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向